BSE filing, NSE: INDOWIND. Summary written from the filing by ALFA Finder's alert engine.
Indowind Energy Ltd: key numbers
- Share price
- ₹8.08
- Market cap
- ₹130.1 Cr
- Revenue (annual)
- ₹40.33 Cr
- Net profit (annual)
- ₹0.00 Cr
- P/E (TTM)
- -692.4×Sector 21.0×
- Promoter holding
- 48.76%+0.56% QoQ
- FII holding
- 0.02%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indowind Energy Ltd
All →Indowind Energy Other Announcement
Indowind Energy Ltd has filed its quarterly shareholding pattern for the quarter ended September 30, 2026, as required by SEBI regulations.
Indowind Energy Legal & Regulatory
Bombay City Civil Court ruled in favour of Indowind in a Commercial Summary Suit against Bank of Baroda. The bank must encash a ₹1 Crore BG plus 12% p.a. interest from 2004.
- Value
- ₹1.00 Cr
Indowind Energy Management Change
Indowind Energy Ltd has appointed Dr. S.R. Shriraam Shekher as an Additional Director in the category of Non-Executive Independent Director, effective 30th September 2026.
Indowind Energy Annual General Meeting
Indowind Energy Ltd held its 31st Annual General Meeting on September 25, 2026. Shareholders transacted all items of business as stated in the notice.
Indowind Energy Management Change
Indowind Energy Ltd announced the resignation of Independent Director Mr. Bathey Ramamurthy Baskaran, effective September 9, 2026. He cited personal commitments for his departure.
Indowind Energy Annual General Meeting
Indowind Energy Limited announced its 31st Annual General Meeting scheduled for September 25, 2026. The meeting agenda includes financial statement adoption and related party transaction approvals.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.